Dr. Reddy’s Q3 Results Net Profit Grows 2% To ₹1,403.8 Crore, Revenue Surges 16%

Dr Reddy’s Q3 results: Net profit grows 2% to ₹1,403.8 crore, revenue surges 16%

Dr. Reddy’s Laboratories Ltd, one of India’s leading pharmaceutical giants, reported its financial results for the third quarter of the fiscal year 2024-25 (Q3 FY25) on Thursday, January 23, 2025. The company’s net profit witnessed a modest 1.8% year-on-year (YoY) growth, reaching ₹1,403.8 crore in Q3 FY25, compared to ₹1,378.9 crore in the corresponding quarter…

Read More
Mphasis Q3 Results Net Profit Up 14.5% Yoy At ₹427.8 Crore, Revenue Rises By 6.7%; Stock Rises Up To 5.4%

Mphasis Q3 Results: Net profit up 14.5% YoY at ₹427.8 crore, revenue rises by 6.7%; stock rises up to 5.4%

Mphasis Ltd, a leading IT services firm, announced its financial results for the third quarter of the fiscal year 2024-25 (Q3 FY25) on Thursday, showcasing strong year-on-year (YoY) growth in revenue and profitability. The company reported a 14.51% YoY increase in net profit, which stood at ₹427.81 crore, compared to ₹373.6 crore in the corresponding…

Read More
Dr Reddy's Stock Plunges 6% As Revlimid Revenue Concerns Loom Large Despite Positive Q3 Earnings

Dr Reddy’s stock plunges 6% as Revlimid revenue concerns loom large despite positive Q3 earnings

Dr Reddy’s Faces Challenges with Revlimid Decline, But Opportunities Lie Ahead Dr Reddy’s Laboratories delivered Q3 earnings that slightly surpassed market expectations, but the spotlight was on the declining revenue from Revlimid, the company’s blockbuster cancer drug. Once a significant growth driver, Revlimid’s contribution to the company’s revenue has been shrinking as its patent expiry…

Read More
Ultratech Cement Q3 Net Profit Declines 17% Yoy To ₹1,469.5 Crore, Revenue Up 2.7%

UltraTech Cement Q3 net profit declines 17% YoY to ₹1,469.5 crore, revenue up 2.7%

UltraTech Cement Q3 Results: Net Profit Declines 17% YoY to ₹1,469.5 Crore, Revenue Up 2.7% UltraTech Cement, the Aditya Birla Group’s flagship company and a leading grey cement manufacturer, reported a 17.3% year-on-year (YoY) decline in its consolidated net profit for the third quarter of the financial year 2024-25 (Q3 FY25). The company’s net profit…

Read More
Hindustan Unilever Stock Declines Nearly 4%, After Net Profit Drops 2.76% At ₹2540 Crore

Hindustan Unilever stock declines nearly 4%, after net profit drops 2.76% at ₹2540 crore

Hindustan Unilever Stock Declines Nearly 4% Following Q3 Earnings Report Shares of Hindustan Unilever Ltd (HUL) witnessed a significant drop of nearly 4% in early trading on Thursday, January 23, 2025, as the company’s December quarter earnings report failed to meet investor expectations. The dip in profit margins and lack of strong growth drivers left…

Read More
Paras Defence And Space Technologies Zooms 9% On Mou With Government Of Maharashtra

Paras Defence and Space Technologies zooms 9% on MoU with Government of Maharashtra

Paras Defence & Space Technologies Jumps 9% on MoU with Maharashtra Government for Optics Park Shares of Paras Defence & Space Technologies Ltd soared by 8.8% on Thursday, January 23, 2025, trading at ₹1,122 apiece on the National Stock Exchange (NSE). The sharp rally came after the company signed a Memorandum of Understanding (MoU) with…

Read More
Coforge Share Price Soars Over 12%, Persistent Systems Up 11% On Q3 Results, Dividend Announcements

Coforge share price soars over 12%, Persistent Systems up 11% on Q3 results, dividend announcements

Coforge Share Price Soars Over 12%, Persistent Systems Gains 11% on Strong Q3 Results and Dividend Announcements Shares of Coforge Ltd and Persistent Systems, leading IT solutions and technology consulting providers, witnessed a stellar rally on Thursday, January 23, 2025, following the release of their financial results for the October-December quarter (Q3 FY25) and the…

Read More
Back To Top